Abstract KRAS is one of the most commonly mutated proteins in cancer, and efforts to directly inhibit its function have been continuing for decades. The most successful of these has been the development of covalent allele-specific inhibitors that trap KRAS G12C in its inactive conformation and suppr...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!